Prostate Cancer - Results from #140

Risk of metabolic and cardiovascular adverse events with abiraterone or enzalutamide among men with advanced prostate cancer. April 15, 2022

A Phase 1b/2 Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men With Metastatic Castration-Resistant Prostate Cancer with Progression on an Androgen Receptor Targeting Agent. April 15, 2022

Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476). April 14, 2022

The quality of life of regional and remote cancer caregivers in Australia. April 14, 2022

Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging : 18F-PSMA-11 PET/CT and Impact on Prostate Cancer Management. April 14, 2022

Prostate Cancer and Sleep Disorders: A Systematic Review. April 14, 2022

Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC. April 14, 2022

Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study. April 13, 2022

Contemporary seminal vesicle invasion rates in NCCN high-risk prostate cancer patients. April 13, 2022

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design. April 13, 2022

A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer. April 13, 2022

Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer. April 13, 2022

Personalized Medicine in Localized Prostate Cancer: Are We There Yet? April 12, 2022

Long-term outcomes of whole gland high-intensity focused ultrasound for localized prostate cancer. April 12, 2022

A Patient-Centered Approach to Research Prioritization in Prostate Cancer. April 12, 2022

Histopathologic and Genetic Features of Mismatch Repair-Deficient High-Grade Prostate Cancer. April 12, 2022

A Pilot Feasibility Study of Digital Health Coaching for Men With Prostate Cancer. April 12, 2022

Prostate cancer polygenic risk score and prediction of lethal prostate cancer. April 12, 2022

Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancer. April 12, 2022

New AI Tool for Prostate MRI Analysis to Support PI-RADS Scoring April 11, 2022

Page 8 of 1223

email news signup